Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Allan-Herndon-Dudley syndrome

Allan-Herndon-Dudley syndrome is a disorder with mental retardation and muscular atrophy that is caused by a triiodothyronine resistance (T3 resistance). It is the result of mutations in the SLC16A2 gene. Inheritance is x-linked dominant.

Systematic

Thyroid hormone resistance
Abnormal thyroid hormone metabolism
Allan-Herndon-Dudley syndrome
SLC16A2
RXRA
Thyroid hormone resistance, generalized, autosomal dominant
Thyroid hormone resistance, generalized, autosomal recessive
Thyroid hormone resistance, selective pituitary

References:

1.

Dumitrescu AM et al. (2004) A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene.

external link
2.

Capri Y et al. (2013) Relevance of different cellular models in determining the effects of mutations on SLC16A2/MCT8 thyroid hormone transporter function and genotype-phenotype correlation.

external link
3.

Vaurs-Barrière C et al. (2009) Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.

external link
4.

Sijens PE et al. (2008) 1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency.

external link
5.

Papadimitriou A et al. (2008) A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay.

external link
6.

Bohan TP et al. (2004) Allan-Herndon-Dudley syndrome: should the locus for this hereditary spastic paraplegia be designated SPG 22?

external link
7.

Zorick TS et al. (2004) Fine mapping and clinical reevaluation of a Brazilian pedigree with a severe form of X-linked mental retardation associated with other neurological dysfunction.

external link
8.

Starling A et al. (2002) Further evidence for a fourth gene causing X-linked pure spastic paraplegia.

external link
9.

Claes S et al. (2000) Novel syndromic form of X-linked complicated spastic paraplegia.

external link
10.

None (1993) X-linked mental retardation: in pursuit of a gene map.

external link
11.

May M et al. (1995) Molecular analysis of four males with mental retardation and deletions of Xq21 places the putative MR region in Xq21.1 between DXS233 and CHM.

external link
12.

Opitz JM et al. (1984) Conference report: International Workshop on the fragile X and X-linked mental retardation.

external link
13.

Schwartz CE et al. (1990) Allan-Herndon syndrome. II. Linkage to DNA markers in Xq21.

external link
14.

Stevenson RE et al. (1990) Allan-Herndon syndrome. I. Clinical studies.

external link
15.

Bundey S et al. (1991) Allan-Herndon syndrome--or X-linked cerebral palsy?

external link
16.

Bundey S et al. (1977) Recurrence risks in families of children with symmetrical spasticity.

external link
17.

Frints SG et al. (2008) MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression.

external link
18.

Maranduba CM et al. (2006) Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter.

external link
19.

Schwartz CE et al. (2005) Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene.

external link
20.

Passos-Bueno MR et al. (1993) Severe nonspecific X-linked mental retardation caused by a proximally Xp located gene: intragenic heterogeneity or a new form of X-linked mental retardation?

external link
21.

Orphanet article

Orphanet ID 59 external link
22.

OMIM.ORG article

Omim 300523 external link
23.

Wikipedia article

Wikipedia EN (Allan–Herndon–Dudley_syndrome) external link
Update: Aug. 14, 2020
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits